Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol

Abstract The two most important and studied phytocannabinoids present in Cannabis sativa L. are undoubtedly cannabidiol (CBD), a non-psychotropic compound, but with other pharmacological properties, and Δ9-tetrahydrocannabinol (Δ9-THC), which instead possesses psychotropic activity and is responsibl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pasquale Linciano, Cinzia Citti, Fabiana Russo, Francesco Tolomeo, Aldo Laganà, Anna Laura Capriotti, Livio Luongo, Monica Iannotta, Carmela Belardo, Sabatino Maione, Flavio Forni, Maria Angela Vandelli, Giuseppe Gigli, Giuseppe Cannazza
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e2be800a38e640f98a7de8fd6927174c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e2be800a38e640f98a7de8fd6927174c
record_format dspace
spelling oai:doaj.org-article:e2be800a38e640f98a7de8fd6927174c2021-12-02T13:58:15ZIdentification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol10.1038/s41598-020-79042-22045-2322https://doaj.org/article/e2be800a38e640f98a7de8fd6927174c2020-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79042-2https://doaj.org/toc/2045-2322Abstract The two most important and studied phytocannabinoids present in Cannabis sativa L. are undoubtedly cannabidiol (CBD), a non-psychotropic compound, but with other pharmacological properties, and Δ9-tetrahydrocannabinol (Δ9-THC), which instead possesses psychotropic activity and is responsible for the recreative use of hemp. Recently, the homolog series of both CBDs and THCs has been expanded by the isolation in a medicinal cannabis variety of four new phytocannabinoids possessing on the resorcinyl moiety a butyl-(in CBDB and Δ9-THCB) and a heptyl-(in CBDP and Δ9-THCP) aliphatic chain. In this work we report a new series of phytocannabinoids that fills the gap between the pentyl and heptyl homologs of CBD and Δ9-THC, bearing a n-hexyl side chain on the resorcinyl moiety that we named cannabidihexol (CBDH) and Δ9-tetrahydrocannabihexol (Δ9-THCH), respectively. However, some cannabinoids with the same molecular formula and molecular weight of CBDH and Δ9-THCH have been already identified and reported as monomethyl ether derivatives of the canonical phytocannabinoids, namely cannabigerol monomethyl ether (CBGM), cannabidiol monomethyl ether (CBDM) and Δ9-tetrahydrocannabinol monomethyl ether (Δ9-THCM). The unambiguously identification in cannabis extract of the n-hexyl homologues of CBD and Δ9-THC different from the corresponding methylated isomers (CBDM, CBGM and Δ9-THCM) was achieved by comparison of the retention time, molecular ion, and fragmentation spectra with those of the authentic standards obtained via stereoselective synthesis, and a semi-quantification of these cannabinoids in the FM2 medical cannabis variety was provided. Conversely, no trace of Δ9-THCM was detected. Moreover, CBDH was isolated by semipreparative HPLC and its identity was confirmed by comparison with the spectroscopic data of the corresponding synthetic standard. Thus, the proper recognition of CBDH, CBDM and Δ9-THCH closes the loop and might serve in the future for researchers to distinguish between these phytocannabinoids isomers that show a very similar analytical behaviour. Lastly, CBDH was assessed for biological tests in vivo showing interesting analgesic activity at low doses in mice.Pasquale LincianoCinzia CittiFabiana RussoFrancesco TolomeoAldo LaganàAnna Laura CapriottiLivio LuongoMonica IannottaCarmela BelardoSabatino MaioneFlavio ForniMaria Angela VandelliGiuseppe GigliGiuseppe CannazzaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Pasquale Linciano
Cinzia Citti
Fabiana Russo
Francesco Tolomeo
Aldo Laganà
Anna Laura Capriotti
Livio Luongo
Monica Iannotta
Carmela Belardo
Sabatino Maione
Flavio Forni
Maria Angela Vandelli
Giuseppe Gigli
Giuseppe Cannazza
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
description Abstract The two most important and studied phytocannabinoids present in Cannabis sativa L. are undoubtedly cannabidiol (CBD), a non-psychotropic compound, but with other pharmacological properties, and Δ9-tetrahydrocannabinol (Δ9-THC), which instead possesses psychotropic activity and is responsible for the recreative use of hemp. Recently, the homolog series of both CBDs and THCs has been expanded by the isolation in a medicinal cannabis variety of four new phytocannabinoids possessing on the resorcinyl moiety a butyl-(in CBDB and Δ9-THCB) and a heptyl-(in CBDP and Δ9-THCP) aliphatic chain. In this work we report a new series of phytocannabinoids that fills the gap between the pentyl and heptyl homologs of CBD and Δ9-THC, bearing a n-hexyl side chain on the resorcinyl moiety that we named cannabidihexol (CBDH) and Δ9-tetrahydrocannabihexol (Δ9-THCH), respectively. However, some cannabinoids with the same molecular formula and molecular weight of CBDH and Δ9-THCH have been already identified and reported as monomethyl ether derivatives of the canonical phytocannabinoids, namely cannabigerol monomethyl ether (CBGM), cannabidiol monomethyl ether (CBDM) and Δ9-tetrahydrocannabinol monomethyl ether (Δ9-THCM). The unambiguously identification in cannabis extract of the n-hexyl homologues of CBD and Δ9-THC different from the corresponding methylated isomers (CBDM, CBGM and Δ9-THCM) was achieved by comparison of the retention time, molecular ion, and fragmentation spectra with those of the authentic standards obtained via stereoselective synthesis, and a semi-quantification of these cannabinoids in the FM2 medical cannabis variety was provided. Conversely, no trace of Δ9-THCM was detected. Moreover, CBDH was isolated by semipreparative HPLC and its identity was confirmed by comparison with the spectroscopic data of the corresponding synthetic standard. Thus, the proper recognition of CBDH, CBDM and Δ9-THCH closes the loop and might serve in the future for researchers to distinguish between these phytocannabinoids isomers that show a very similar analytical behaviour. Lastly, CBDH was assessed for biological tests in vivo showing interesting analgesic activity at low doses in mice.
format article
author Pasquale Linciano
Cinzia Citti
Fabiana Russo
Francesco Tolomeo
Aldo Laganà
Anna Laura Capriotti
Livio Luongo
Monica Iannotta
Carmela Belardo
Sabatino Maione
Flavio Forni
Maria Angela Vandelli
Giuseppe Gigli
Giuseppe Cannazza
author_facet Pasquale Linciano
Cinzia Citti
Fabiana Russo
Francesco Tolomeo
Aldo Laganà
Anna Laura Capriotti
Livio Luongo
Monica Iannotta
Carmela Belardo
Sabatino Maione
Flavio Forni
Maria Angela Vandelli
Giuseppe Gigli
Giuseppe Cannazza
author_sort Pasquale Linciano
title Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
title_short Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
title_full Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
title_fullStr Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
title_full_unstemmed Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
title_sort identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/e2be800a38e640f98a7de8fd6927174c
work_keys_str_mv AT pasqualelinciano identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT cinziacitti identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT fabianarusso identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT francescotolomeo identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT aldolagana identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT annalauracapriotti identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT livioluongo identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT monicaiannotta identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT carmelabelardo identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT sabatinomaione identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT flavioforni identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT mariaangelavandelli identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT giuseppegigli identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
AT giuseppecannazza identificationofanewcannabidiolnhexylhomologinamedicinalcannabisvarietywithanantinociceptiveactivityinmicecannabidihexol
_version_ 1718392233164537856